Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

MEA Colorectal Cancer Companies

Colorectal cancer treatment in the Middle East and Africa is primarily provided by a combination of public and private healthcare institutions. Several pharmaceutical and biotechnology companies play a crucial role in developing and providing treatment options

Middle East and Africa Colorectal Cancer Key Companies

 

Latest Middle East and Africa Colorectal Cancer Companies Update


AstraZeneca Secured regulatory approval for Imfinzi (durvalumab) for the treatment of stage III colorectal cancer in several MEA countries. This expands access to a key checkpoint inhibitor therapy.


Roche Launched Elepsys (bevacizumab) in combination with chemotherapy for the treatment of metastatic colorectal cancer in several MEA markets. This provides another targeted therapy option for advanced disease


Johnson & Johnson Partnered with local healthcare institutions in Egypt and South Africa to implement training programs for colorectal cancer screening and diagnosis.


Merck KGaA Collaborating with regional oncology centers to establish clinical research networks for the development and evaluation of new colorectal cancer treatments in the MEA region.


List of Middle East and Africa Colorectal Cancer Key Companies in the Market



  • Hoffmann-La Roche Ltd (Switzerland)

  • Amgen Inc. (US)

  • Novartis AG(Switzerland)

  • Abbott (US)

  • Beckman Coulter Inc. (US)

  • Debiopharm Group (Switzerland)

  • AbbVie Inc. (US)

  • Bayer AG (Germany)


Market Synopsis of Middle-East and Africa Colorectal Cancer Market:


Market Scenario:


The Middle-East and Africa Colorectal Cancer market is anticipated to reach USD 2,215.8 Million by 2030 at 4.8% CAGR during the forecast period 2022-2030. The colon and rectum belong to our body's digestive system - together they are also known as the large bowel. Colorectal cancer is cancer that starts in the colon or rectum. Colorectal cancer (CRC), also known as bowel cancer and colon cancer. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Each year, around 5,000 Saudis are diagnosed with having cancer, such as colon cancer and breast cancer. Middle-East and Africa Colorectal Cancer market is growing steadily.


Study Objectives of Middle-East and Africa Colorectal Cancer Market:

  • To provide detailed analysis of the market structure along with forecast for the next 5 years of the various segments and sub-segments of the Middle-East and Africa Colorectal Cancer market

  • To provide insights about factors affecting the market growth

  • To analyze the Middle-East and Africa Colorectal Cancer market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries- Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by type, by diagnosis, by treatment type and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle-East and Africa Colorectal Cancer market.


Middle-East and Africa Colorectal Cancer Market by Treatment Type Colorectal Cancer Market by Treatment Type


Intended Audience

  • Middle-East and Africa Colorectal Cancer Equipment manufacturers

  • Middle-East and Africa Colorectal Cancer Equipment Suppliers

  • Government and Independent Regulatory Authorities

  • Research and Development (R&D) Companies

  • Independent Research Laboratories

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories


Segments:


Middle-East and Africa Colorectal Cancer market has been segmented on the basis of type which Adenocarcinomas, Carcinoid tumors, Gastrointestinal stromal tumors (GISTs), Lymphomas, Sarcomas, and others. On the basis of diagnosis the market is segmented into Faecal Occult Blood Test, Colonoscopy, Virtual Colonoscopy, Stool DNA test, Digital Rectal Examination, Flexible Sigmoidoscopy, Biopsy, Magnetic resonance imaging (MRI), and Others. On the basis of treatment type market is segmented into Surgery, Radiation Therapy, Chemotherapy, targeted drug therapy, and others.


Regional Analysis of Middle-East and Africa Colorectal Cancer Market:   


Considering the Middle-East and Africa Colorectal Cancer Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Colorectal Cancer. Moreover Saudi Arabia market is also growing and second largest market for Patient monitoring devices. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Colorectal Cancer during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.


Key Players for Middle-East and Africa Colorectal Cancer Market: 


Some of the key players in this market are: F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Novartis AG(Switzerland), Abbott (US), Beckman Coulter Inc. (US), Debiopharm Group (Switzerland), AbbVie Inc. (US), Bayer AG (Germany).


The report for Middle-East and Africa Colorectal Cancer Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.